Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

Micrus Endovascular to Present at the Canaccord Cardiovascular Conference

Posted : Wed, 04 Nov 2009 21:26:20 GMT
Author : Micrus Endovascular Corporation
Category : Press Release
News Alerts by Email ( click here )
News | Home
SAN JOSE, Calif. - (Business Wire) Micrus Endovascular Corporation (NASDAQ: MEND) today announced that Robert Stern, President and Chief Operating Officer, will present at the third annual Canaccord Cardiovascular Conference on Tuesday, November 10, 2009, at 4:00 p.m. Pacific time (7:00 p.m. Eastern time) at the Hotel Nikko in San Francisco.

Live webcast of the conference presentations will be available via the Internet by visiting the Investor Relations section of Micrus’ Web site at www.micruscorp.com. An archive of these presentations will be available on the Web site for 14 days.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Hemorrhagic and ischemic stroke are both significant causes of death and disability worldwide. The Micrus product lines enable physicians to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. Micrus’ proprietary, three-dimensional microcoils anatomically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells stents, balloon catheters, access devices such as guide catheters, microcatheters, guidewires and accessory products used in conjunction with its microcoils. For more information, visit www.micruscorp.com.

Micrus Endovascular Corporation
Gordon Sangster
Vice President, Chief Financial Officer
408-433-1400
gsangster@micruscorp.com
or
Investor Contacts:
Lippert/Heilshorn & Associates, Inc.
310-691-7100
Jody Cain, jcain@lhai.com
Bruce Voss, bvoss@lhai.com


Copyright © 2008 Business Wire. All rights reserved.
Share/Save/Bookmark

Article : Micrus Endovascular to Present at the Canaccord Cardiovascular Conference
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

Cyber Thanksgiving Online Shopping a Growing Tradition
NEW YORK, Nov. 26 /PRNewswire/ -- According to the Bergen Record, "In homes across America, there's a Thanksgiving tradition getting bigger every year, and having an impact on the nation's retailers. After passing the turkey, Americans are reaching for the mouse. Thanksgiving D...

AU Optronics Honored with 2009 / 2010 Ocean Tomo 300(R) Patent Index
HSINCHU, Taiwan, Nov. 26 /PRNewswire-Asia/ -- AU Optronics Corp. ("AUO" or the "Company") (TAIEX: 2409; NYSE: AUO) announced today that it is honored with the 2009 / 2010 Ocean Tomo 300(R) Patent Index. It indicates high recognition fo...

Katarina Bylund Appointed New Senior Vice President of Group Staff Unit Reporting at Skanska
STOCKHOLM - Regulatory News: Katarina Bylund has been appointed new Senior Vice President Reporting at Skanska (STO:SKAB) from April 1, 2010. She will succeed Mats Moberg, who will retire at the end of the first quarter of 2010. From January, Katarina B

Naspers Limited Today Announced Results for the Six Months Ended 30 September 2009
CAPE TOWN - Naspers (JSE:NPN) (LSE:NPSN) today reported a 6% increase in revenue to R13,5 billion for the six months ended 30 September 2009. Operating profit (before amortisation and other gains and losses) grew by 19% to R2,8 billion. Core headline earnings were up t

Galapagos receives EUREKA innovation label and OSEO funding
MECHELEN, BELGIUM -- 11/26/09 -- Mechelen, Belgium; 26 November 2009 - Galapagos NV (Euronext: GLPG) announces that its antibody therapeutics program with MorphoSys and SARM program have been awarded funding by the French gove..

TELEPERFORMANCE : Financial Meeting - November 26, 2009
PARIS -- 11/26/09 -- Objectives 2009 - Revenues +2.5% - Based on published data -1.3% - On a comparable basis* - EBITA** - excl. non-recurring items EUR 154 - 155 million 8.5% of revenues Outlook f..

New Zealand Beach Front Property Offers Global Currency Rate Bargains
Although the median price of the average New Zealand home has remained relatively stable since January, 2009 (1 April, 09 Bloomberg Report); the price decrease of 8% over the last year, and the NZ dollar decline of between 16 and 28 percent against the Euro and US currencies respectively duri...

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.